arrow_back Back to App

Global COVID-19 Response and Future Pandemic Preparedness Act

This act aims to protect U.S. citizens from new COVID-19 variants through global action. It establishes a program to coordinate the international pandemic response, striving for rapid vaccination of most populations in low- and middle-income countries. Additionally, it seeks to prevent future pandemics through a global early warning and disease surveillance system.
Key points
Establishment of a program to coordinate the global fight against COVID-19 and prepare for future pandemics, protecting U.S. citizens from new virus variants.
Scaling up global vaccine production and distribution, aiming to vaccinate at least 60% of populations in 92 low- and middle-income countries by the beginning of the second quarter of 2022.
Creation of a global disease surveillance and early warning system to prevent future pandemics and respond quickly to new health threats.
Authorization of $34 billion for the program, including for vaccine manufacturing, delivery, administration, and building a global surveillance network.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_1976
Sponsor: Sen. Merkley, Jeff [D-OR]
Process start date: 2021-06-08
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

NOVID Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_1976.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-06-08.

What are the main provisions?

Key points include:

  • Establishment of a program to coordinate the global fight against COVID-19 and prepare for future pandemics, protecting U.S. citizens from new virus variants.
  • Scaling up global vaccine production and distribution, aiming to vaccinate at least 60% of populations in 92 low- and middle-income countries by the beginning of the second quarter of 2022.
  • Creation of a global disease surveillance and early warning system to prevent future pandemics and respond quickly to new health threats.
  • Authorization of $34 billion for the program, including for vaccine manufacturing, delivery, administration, and building a global surveillance network.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Merkley, Jeff [D-OR].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

CATEGORIES

Health Public Investments